Soluble forms of CD44 and CD54 (ICAM-1) cellular adhesion molecules are released by human prostatic cancer cell lines

Cancer Letters

Volumn 107, Issue 1, 1996, Pages 29-35

  Rokhlin, Oskar W ^a   Cohen, Michael B ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Prostatic neoplasms; Soluble CD44; Soluble CD54

Indexed keywords

GAMMA INTERFERON; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE TUMOR; SUPERNATANT;

EID: 0030272159     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04339-X     Document Type: Article

References (27)

1. [1] McCarthy, J.B., Skubitz, A.P.N., Ilda, J., Mooradian, D.L., Wilke, M.S. and Furcht, L.T. (1991) Tumor cell adhesive mechanisms and their relationship to metastasis, Semin. Cancer Biol., 2, 155-167.
2. [2] Rose-John, S. and Heinrich, P.C. (1994) Soluble receptors for cytokines and growth factors: generation and biological function, Biochem. J., 300, 281-289.
3. [3] Gearing, A.J. and Newman, W. (1993) Circulating adhesion molecules in disease, Immunol. Today, 14, 506-509.
4. [4] Denning, S.M., Telen, M.J., Hale, L.P., Liao, H.X. and Haynes, B.F. (1995) CD44 and CD44R clusters. In: Leucocyte Typing V, pp. 1713-1718. Editors: S.E. Schlossman, L. Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T.F. Tedder and R.F. Todd. Oxford University Press, Oxford.
5. [5] Haynes, B.F., Hale, L.P., Patton, K.L., Martin, M.E. and McCallum, R.M. (1991) Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Upregulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis, Arthritis Rheumatism, 34, 1434-1443.
6. [6] Guo, Y.-J., Liu, G., Wang, X., Jin, D., Wu, M., Ma, J. and Sy, M.-S. (1994) Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer, Cancer Res., 54, 422-426.
7. [7] Mackay, C.R. and Imhof, B.A. (1993) Cell adhesion in immune system, Immunol. Today, 14, 99-102.
8. [8] Tsujisaki, M., Imai, K., Hirata, H., Hanzawa, Y., Masuya, J., Nakano, T., Sugiyama, T., Matsui, M., Hinoda, Y. and Yachi, A. (1991) Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases, Clin. Exp. Immunol., 85, 3-8.
9. [9] Harning, R., Mainolfi, E., Bystryn, J.-C., Henn, M., Merluzzi, V.J. and Rothlein, R. (1991) Serum levels of circulating intercellular adhesion molecule-1 in human malignant melanoma, Cancer Res., 51, 5003-5005.
10. [10] Becker, J.C., Dummer, R., Schwinn, A., Hartmann, A.A. and Burg, G. (1992) Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin therapy, J. Immunother., 12, 147-150.
11. [11] Giavazzi, R., Chirivi, R.G.S., Garofalo, A., Rambaldi, A., Hemingway, I.K., Piggot, R. and Gearing, A.J.H. (1992) Soluble intercellular adhesion molecule 1 is released by human melanoma cells and is associated with tumor growth in nude mice, Cancer Res., 52, 2628-2630.
12. [12] Rokhlin, O.W. and Cohen, M.B. (1995) Expression of cellular adhesion molecules on human prostate tumor cell lines, Prostate, 26, 205-212.
13. [13] Rokhlin, O.W. and Cohen, M.B. (1995) Differential sensitivity of human prostatic cancer cell lines to the effects of protein kinase and phosphatase inhibitors, Cancer Lett., 98, 103-110.
14. [14] Stevens, J.W., Palechek, P.L., Griebling, T.L., Midura, R.J., Rokhlin, O.W. and Cohen, M.B. (1996) Expression of CD44 isoforms in human prostate tumor cell lines, Prostate, 28, 153-161.
15. [15] Narayan, P. and Dahiya, R. (1992) Establishment and characterization of a human primary prostate adenocarcinoma cell line (ND-1), J. Urol., 148, 1000-1004.
16. [16] Loop, S.M., Rozanski, T.A. and Ostenson, R.C. (1993) Human primary prostate tumor cell line, ALVA-31: A new model for studying the hormonal regulation of prostate tumor cell growth, Prostate, 22, 93-108.
17. [17] Muraki, J., Addonizio, J.C., Choundhury, M.S., Fisher, J., Eshghi, M., Davidian, M.M., Shapiro, L.R., Wilmot, P.L., Nagamatsu, G.R. and Chiao, J.W. (1990) Establishment of new human prostatic cancer cell line (JCA-1), Urology, 36, 79-84.
18. [18] Rubin, L.A., Kurman, C.C., Fritz, M.E., Biddison, W.E., Bantin, B., Yarchoan, R. and Nelson, D.L. (1985) Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro., J. Immunol., 135, 3172-3179.
19. [19] Goodwin, R.G., Friend, D., Ziegler, S.F., Jerzy, R., Falk, B.A., Gimpel, S., Cosman, D., Dower, S.K., March, C.J., Namen, A.E. and Park, L.S. (1990) Cloning of the human and murine interleukin 7 receptors: demonstration of a soluble form and homology to a new receptor superfamily, Cell, 60, 941-950.
20. [20] Makgoba, M.W., Sanders, M.E., Ginther-Luce, G.E., Gugel, E.A., Dustin, M.L., Springer, T.A. and Shaw, S. (1988) Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity, Eur. J. Immunol., 18, 637-640.
21. [21] Galandrini, R., Albi, N., Tripodi, G., Zarcone, D., Terenzi, A., Moretta, A., Grossi, C.E. and Veraldi, A. (1993) Antibodies to CD44 trigger effector functions of human T cell clones, J. Immunol., 150, 4225-4235.
22. [22] Sconocchia, G., Titus, J.A. and Segal, D.M. (1994) CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells, J. Immunol., 153, 5473-5481.
23. [23] Becker, J.C., Dummer, R., Hartman, A.A., Burg, G. and Schmidt, R.E. (1991) Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α, J. Immunol., 147, 4398-4401.
24. [24] Banks, R.E., Gearing, A.J.H., Hemingway, I.K., Norfolk, D.R., Perren, T.J. and Selby, P.J. (1993) Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies, Br. J. Cancer, 68 (VCAM-1), 122-124.
25. [25] Reap, B.O., Heidenthat, E., deVries, R.R.P., Kolb, H. and Martin, S. (1994) Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus, Lancet, 343, 1590-1592.
26. [26] Reilly, P.L., Woska, J.R., Jeanfavre, D.D., McNally, E., Rothlein, R. and Bormann, B.-J. (1995) The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1, J. Immunol., 155, 529-532.
27. [27] Meyer, D.M., Dustin, M.L. and Carron, C.P. (1995) Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1 ) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1, J. Immunol., 155, 3578-3584.